DXB
Click for more information
7.22% 45.0¢ dimerix limited

PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal...

  1. shlok
    100 Posts.
    lightbulb Created with Sketch. 21
    clock Created with Sketch.
    02/04/24
    14:44
    Post #: 73149921
    PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant

    As far as I can find:

    https://clinicaltrials.gov/study/NCT03763643

    this is the only randomised trial underway due for completion in 2026 and this is for post transplant patients.

    DXB Price at posting: 29.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
OBM Ora Banda sees FY26 gold output jumping to 150Koz/pa following key approval for Sand King
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
NEWS Hillcrest Energy Unveils Power Factor Correction Prototype to Meet Growing Demand
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
45.0¢ 		Change
-0.035(7.22%) 		Mkt cap ! $247.5M
Open High Low Value Volume
48.5¢ 48.5¢ 44.5¢ $1.897M 4.104M

Buyers (Bids)

No. Vol. Price($)
3 79166 45.0¢
 

Sellers (Offers)

Price($) Vol. No.
45.5¢ 103477 2
View Market Depth
Last trade - 16.10pm 11/07/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.